Clinical Trials · NCT02008682
The Efficacy and Safety of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin in Chinese Subjects With Type 2 Diabetes
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 368
- Start date
- Dec 2013
- Locations
- 25 sites, China
- Primary endpoint
- Change From Baseline in Glycosylated Haemoglobin (HbA1c)